HCTI
HCTI
NASDAQ · Health Care

Healthcare Triangle Inc

$0.15
-0.06 (-28.81%)
As of Feb 8, 2:35 PM ET ·
HCTI News7 articles
HCA Healthcare Holds Gains After Strong Profit Outlook, $10B Buyback
HCA Healthcare stock maintained after-hours gains after a sharp rally, fueled by an upbeat profit outlook and a massive new buyback authorization. Investors now eye key economic data.
Earnings 2d ago
Tenet Healthcare Soars on Strong Q4, Upbeat 2026 Profit Forecast
Tenet Healthcare shares surged 16% after posting robust fourth-quarter earnings and raising its 2026 adjusted EBITDA outlook to $4.485–$4.785 billion. The company flagged a potential $250 million headwind from expiring ACA subsidies.
Earnings 3d ago
Amazon Shares Retreat as Investors Assess AI Capex and Healthcare Expansion
Amazon stock declined 0.7% Wednesday as markets weighed the company's substantial AI investment plans and a major pharmacy delivery expansion.
Technology 3d ago
Johnson & Johnson Shares Dip in Extended Trading Amid Healthcare Sector Weakness
Johnson & Johnson stock declined 0.6% in after-hours trading Monday as healthcare stocks underperformed the broader market. The company faces ongoing talc litigation and will present at an industry conference next month.
Markets 5d ago
Johnson & Johnson Shares Retreat Amid Healthcare Sector Weakness
Johnson & Johnson stock declined 1.1% as healthcare stocks underperformed the broader market. Traders are eyeing upcoming U.S. jobs and inflation data for direction.
Markets 5d ago
Sigma Healthcare Shares Dip Ahead of Key Half-Year Results
Sigma Healthcare shares declined nearly 1% in Monday trading as investors await the company's half-year financial report due February 26, focusing on margin performance and cost management.
Earnings 6d ago
Healthcare Sector Sees Divergence: Molina Plunges on Outlook, XLV Gains Amid Regulatory Warnings
Molina Healthcare plummeted 25.5% after slashing its 2026 profit forecast and announcing a Medicare Part D exit, while the Health Care Select Sector SPDR Fund (XLV) rose 1.8%. Regulatory warnings on compounded obesity drugs added pressure to the sector.
Earnings Feb 7